InvestLog
DNTH logo

DNTH

Dianthus Therapeutics, Inc.NASDAQHealthcare
$86.00+1.70%ClosedMarket Cap: $3.30B

As of 2026-04-06

Insider Statistics (Q1 2026)

Purchases

19

Sales

35

Buy/Sell Ratio

0.54

Total Bought

$0.00

Total Sold

$21.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Wed Apr 01Savitz Ryanofficer: EVP, CFO & CBOSell1,390$78.33112,977
Wed Apr 01Savitz Ryanofficer: EVP, CFO & CBOSell40,000$17.88114,367
Wed Apr 01Savitz Ryanofficer: EVP, CFO & CBOSell74,367$8.4474,367
Wed Apr 01Savitz Ryanofficer: EVP, CFO & CBOSell2,366$82.8486,501
Wed Apr 01Savitz Ryanofficer: EVP, CFO & CBOSell800$81.3688,867
Wed Apr 01Savitz Ryanofficer: EVP, CFO & CBOSell1,485$80.2589,667
Wed Apr 01Savitz Ryanofficer: EVP, CFO & CBOSell21,825$78.8691,152
Wed Apr 01Savitz Ryanofficer: EVP, CFO & CBOSell59,800$83.9026,701
Thu Mar 26Soteropoulos PauladirectorSell27,594$78.050
Thu Mar 26Soteropoulos PauladirectorSell27,594$8.4427,594
Tue Mar 17Garcia Marinodirector, officer: CEO AND PRESIDENTSell5,592$17.88269,408
Tue Mar 17Garcia Marinodirector, officer: CEO AND PRESIDENTSell59,700$6.7059,700
Fri Mar 13Garcia Marinodirector, officer: CEO AND PRESIDENTSell12,796$82.601,100
Fri Mar 13Garcia Marinodirector, officer: CEO AND PRESIDENTSell43,505$80.6979,413
Fri Mar 13Garcia Marinodirector, officer: CEO AND PRESIDENTSell122,918$6.70122,918